With 57.7 million shares changed hands, the volume of the stock remained heavier than its average volume of 20.2 million shares. The 52-week range on RXRX shows that it touched its highest point at $15.74 and its lowest point at $5.60 during that stretch. It currently has a 1-year price target of $9.00. Beta for the stock currently stands at 0.88.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of RXRX was up-trending over the past week, with a rise of 41.91%, but this was up by 66.46% over a month. Three-month performance surged to 57.31% while six-month performance rose 61.28%. The stock lost -12.55% in the past year, while it has gained 60.80% so far this year. A look at the trailing 12-month EPS for RXRX yields -1.53 with Next year EPS estimates of -1.65. For the next quarter, that number is -0.41. This implies an EPS growth rate of 2.61% for this year and -7.31% for next year. EPS is expected to grow by 4.49% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -43.41%.
Float and Shares Shorts:
At present, 390.76 million RXRX shares are outstanding with a float of 296.92 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for RXRX since 3 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.45054 being high and -$1.62696 being low. For RXRX, this leads to a yearly average estimate of -$1.53875. Based on analyst estimates, the high estimate for the next quarter is -$0.34 and the low estimate is -$0.8. The average estimate for the next quarter is thus -$0.48.
